Inscripta | search
Click here to view Inscripta news from 60+ newspapers.
Bookmark or Share- Gene Editing with MAD7 TM in yeast Quick Start Guide - Inscripta®Inscripta may refer to the products or services offered by third party companies by their brand name for clarity and does not claim any rights in those third-party brand names. For Research Use Only. Not for use in diagnostic procedures. Document 1002294 Rev B. 03152021 . Author:
- Contact Us - Inscripta®Our revolutionary digital genome engineering tools transform how we face complex global challenges and yield solutions that benefit all.
- INSCRIPTA® ACQUIRES INFINOME BIOSCIENCES AND SESTINA BIO TO ADVANCE ...Inscripta, a global leader in genome engineering technology, announced today the acquisition of two pioneers of synthetic biology – Infinome Biosciences and Sestina Bio, which advance Inscripta’s strategy to develop and commercialize bio-manufactured products for a broad spectrum of industrial and consumer markets.
- Inscripta® Launches the World’s First Benchtop Platform for Digital ...Inscripta, Inc., today announced the launch of the Onyx™ Digital Genome Engineering platform, the world’s first fully automated benchtop instrument for genome-scale engineering.
- Inscripta’s MAD7™ CRISPR Nucleases Helping Hudson River Biosciences ...In a recent webinar, Ben Mijts, Senior Director of Enzyme Engineering at Inscripta, and Gabino Sanchez, Business Development Director at Hudson River Biotechnology, demonstrate how Inscripta’s MADzyme™ family of CRISPR nucleases help scientists edit plant cells for various applications.
More
